Ribosomopathies: human disorders of ribosome dysfunction - PubMed (original) (raw)
Review
Ribosomopathies: human disorders of ribosome dysfunction
Anupama Narla et al. Blood. 2010.
Abstract
Ribosomopathies compose a collection of disorders in which genetic abnormalities cause impaired ribosome biogenesis and function, resulting in specific clinical phenotypes. Congenital mutations in RPS19 and other genes encoding ribosomal proteins cause Diamond-Blackfan anemia, a disorder characterized by hypoplastic, macrocytic anemia. Mutations in other genes required for normal ribosome biogenesis have been implicated in other rare congenital syndromes, Schwachman-Diamond syndrome, dyskeratosis congenita, cartilage hair hypoplasia, and Treacher Collins syndrome. In addition, the 5q- syndrome, a subtype of myelodysplastic syndrome, is caused by a somatically acquired deletion of chromosome 5q, which leads to haploinsufficiency of the ribosomal protein RPS14 and an erythroid phenotype highly similar to Diamond-Blackfan anemia. Acquired abnormalities in ribosome function have been implicated more broadly in human malignancies. The p53 pathway provides a surveillance mechanism for protein translation as well as genome integrity and is activated by defects in ribosome biogenesis; this pathway appears to be a critical mediator of many of the clinical features of ribosomopathies. Elucidation of the mechanisms whereby selective abnormalities in ribosome biogenesis cause specific clinical syndromes will hopefully lead to novel therapeutic strategies for these diseases.
Figures
Figure 1
Simplified schematic of eukaryotic ribosome biogenesis. Adapted from Liu and Ellis with permission.
Figure 2
Selected physical abnormalities seen in ribosomopathies. (A) Left panel: Patient with DBA, illustrating the characteristic craniofacial abnormalities (courtesy of J. Lipton). Note the absent lower eyelashes, deformed external ears, and micrognathia. Second panel: An example of the triphalangeal thumb seen in DBA patients (courtesy of E. Atsidaftos and E. Muir). First panel: Reprinted from Lipton and Ellis with permission. (B) These panels illustrate the diagnostic triad of DKC, including dystrophic fingernails, lacy/reticular pigmentation on neck and trunk, and oral leukoplakia (courtesy of B. Alter). Reprinted from Savage and Alter with permission. (C) The craniofacial abnormalities of a patient with TCS are illustrated (courtesy of M. R. Passos Bueno). Note the down slanting palpebral fissures, malar and maxillary hypoplasia, and malformation of the ears. Reprinted from Passos-Bueno et al with permission.
Figure 3
Potential mechanisms for the cellular consequences of ribosomal haploinsufficiency. (A) Top panel: Normal cell in unstressed conditions, with unperturbed ribosome biogenesis and steady levels of p53. Bottom panel: Ribosomal haploinsufficiency leads to up-regulation of rpL11, which binds to MDM2 causing p53 activation, which results in apoptosis and cell-cycle arrest. (B) Top panel: Normal hemoglobin synthesis, with the coordinated production of heme and globin. Bottom panel: Relative excess of free heme leads to oxidative stress and hemolysis through a variety of mechanisms.
Similar articles
- How Altered Ribosome Production Can Cause or Contribute to Human Disease: The Spectrum of Ribosomopathies.
Venturi G, Montanaro L. Venturi G, et al. Cells. 2020 Oct 15;9(10):2300. doi: 10.3390/cells9102300. Cells. 2020. PMID: 33076379 Free PMC article. Review. - Non-Diamond Blackfan anemia disorders of ribosome function: Shwachman Diamond syndrome and 5q- syndrome.
Burwick N, Shimamura A, Liu JM. Burwick N, et al. Semin Hematol. 2011 Apr;48(2):136-43. doi: 10.1053/j.seminhematol.2011.01.002. Semin Hematol. 2011. PMID: 21435510 Free PMC article. Review. - Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
Boultwood J, Yip BH, Vuppusetty C, Pellagatti A, Wainscoat JS. Boultwood J, et al. Adv Biol Regul. 2013 Jan;53(1):8-17. doi: 10.1016/j.jbior.2012.09.002. Epub 2012 Sep 13. Adv Biol Regul. 2013. PMID: 23031788 Review. - Acquired ribosomopathies in leukemia and solid tumors.
Vlachos A. Vlachos A. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):716-719. doi: 10.1182/asheducation-2017.1.716. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222326 Free PMC article. Review. - Ribosome defects in disorders of erythropoiesis.
Narla A, Hurst SN, Ebert BL. Narla A, et al. Int J Hematol. 2011 Feb;93(2):144-149. doi: 10.1007/s12185-011-0776-0. Epub 2011 Feb 1. Int J Hematol. 2011. PMID: 21279816 Free PMC article. Review.
Cited by
- Emerging insights into epigenetics and hematopoietic stem cell trafficking in age-related hematological malignancies.
Xinyi Y, Vladimirovich RI, Beeraka NM, Satyavathi A, Kamble D, Nikolenko VN, Lakshmi AN, Basappa B, Reddy Y P, Fan R, Liu J. Xinyi Y, et al. Stem Cell Res Ther. 2024 Nov 6;15(1):401. doi: 10.1186/s13287-024-04008-4. Stem Cell Res Ther. 2024. PMID: 39506818 Free PMC article. Review. - USP4 regulates ribosome biogenesis and protein synthesis for hematopoietic stem cell regeneration and leukemia progression.
Liu B, Zhang X, Zhou Y, Liu H, Wang Z, Fu Y, Gao Q, Cheng X, Sun Q, Ju Z. Liu B, et al. Leukemia. 2024 Nov;38(11):2466-2478. doi: 10.1038/s41375-024-02338-z. Epub 2024 Sep 12. Leukemia. 2024. PMID: 39266638 - RNA binding protein-directed control of leukemic stem cell evolution and function.
Joshi P, Keyvani Chahi A, Liu L, Moreira S, Vujovic A, Hope KJ. Joshi P, et al. Hemasphere. 2024 Aug 22;8(8):e116. doi: 10.1002/hem3.116. eCollection 2024 Aug. Hemasphere. 2024. PMID: 39175825 Free PMC article. Review. - Cancer-specific alterations in nuclear matrix proteins determined by multi-omics analyses of ductal carcinoma in situ.
Almutairy AF, Alhamed AS, Grant SG, Falso MJ, Day BW, Simmons CR, Latimer JJ. Almutairy AF, et al. Front Oncol. 2024 Aug 6;14:1406946. doi: 10.3389/fonc.2024.1406946. eCollection 2024. Front Oncol. 2024. PMID: 39165691 Free PMC article. - Ribosome Biogenesis and Cancer: Insights into NOB1 and PNO1 Mechanisms.
Ragunath M, Shen A, Wei L, Peng J, Thiruvengadam M. Ragunath M, et al. Curr Pharm Des. 2024;30(37):2911-2921. doi: 10.2174/0113816128301870240730071910. Curr Pharm Des. 2024. PMID: 39143880 Review.
References
- Draptchinskaia N, Gustavsson P, Andersson B, et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet. 1999;21(2):169–175. - PubMed
- Liu JM, Ellis SR. Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood. 2006;107(12):4583–4588. - PubMed
- Doudna JA, Rath VL. Structure and function of the eukaryotic ribosome: the next frontier. Cell. 2002;109(2):153–156. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous